Preparedness – Publications and Reports

Publications and Reports

2011

Barker, S., Charlton, N.P., Holstege, C.P. “Internet accuracy regarding snake envenomation in prehospital care.” Wilderness Environmental Medicine (publication pending).

Forrester, J., Holstege, C.P. “Bilateral Paronychia: Infection with Streptococcus pyogenes.” Wilderness Environ Med (accepted, publication pending).

Charlton, N.P., Lawrence, D.T., Bechtel, L.K., Holstege, C.P. “5-oxoproline induced anion gap metabolic acidosis following an acute acetaminophen overdose.” J Am Osteopath Assoc (accepted, publication pending).

Smith, M., Charlton, N., Holstege, C.P. “Caterpillar dermatitis.” Wilderness Environ Med (accepted, publication pending).

Mitchell, S., Holstege, C.P. “Electrocardiogram in toxicology.” Brady, W.J., et al (eds). 2011 publication pending.

Thomas, J.J., St. Amant, J., Brady, W.J., Burt, D.R., Holstege, C.P., Ghaemmaghami, C.A. “Emergency physicians are reliable at cardiac cath lab activation in the setting of acute STEMI.” Critical Pathways in Cardiology (publication pending).

2010

Painting by Numbers: Capturing the Pathology of Socio-Political ConflictPsychiatry: Interpersonal & Biological Processesby Greg Saathoff, M.D.

Stern, E et al (2010 in press) European Vaccine Strategy Assessment Report (Comparative Analysis of EU Member States’s HINI Vaccine Strategy and Risk Communication). Commissioned by the EU Commission Health Policy Directorate and conducted in Partnership with the UK Health Protection Agency.

Schouten, R., Saathoff, G, Biosurety in the Post-9/11 Era, Chapter 14, in Microbial Forensics, Elsevier, Inc, 2010. (accepted for publication, December 2010)

Bechtel, L.K., Lawrence, D., Holstege, C.P. “Ingestion of False Hellebore Plants Can Cross-react with a Digoxin Clinical Chemistry Assay.” Clinical Toxicol 2010;48(5):435-442.

Louters, L.L., Stehouwer, N., Rekman, J., Tidball, A., Cok, A., Holstege, C.P. “Verapamil inhibits the glucose transporter GLUTI.” J. Med Toxicol 2010.

Rowden, A., Holstege, C.P., Buck, M., Eldridge, D. “Radiopacity of Ingested Transdermal Medicinal Patches: A Simulated Human Model.” Am J Emerg Med. 2010;28(4):492-3.

Garcia, D., Mattu, A., Holstege, C.P., Brady, W.J. “Intraventricular Conduction Abnormality-An Electrocardiographic Algorithm for Rapid Diagnosis.” Am J Emerg Med 2010;28(1):95-102.

Forrester, J.D., Holstege, C.P. “Medical Mystery: Ramp (Allum tricocca) mimicker intoxication.” Wilderness Environ Med 2010;21:164-5.

Charlton, N.P., Lawrence, D.T., Brady, W.A., Kirk, M.A., Holstege, C.P. “Correction of Torsades de Pointes with Overdrive Pacing.” Am J Emerg Med 2010;28:95-102.

Maniscalco, P.M., Christen, H.T., Holstege, C.P., Saathoff, G.B. “Multiple Casuality Incident.” In Keim (eds) Textbook of Emergency Medicine. Wolters Kluwer Health (Lippincott). 2010 (publication pending).

Charlton, N., Holstege, C.P. “Medical Toxicology.” In Herrigan (eds) Emergency Medicine Board Review Book. 2010 (publication pending).

Reilly, T.K., Taki, K., Holstege, C.P. “Respiratory involvement from herbals.” In Camus P and Rosenow E.C. (eds): Drug-Induced and Iatrogenic Lung Disease. Hodder Arnold, London. 2010 (publication pending).

Holstege, C.P., Lawrence, D. “The Evaluation and Management of Acute Poisoning Emergencies.” 4th Edition National Association of EMS PhyPrehospital Systems and Medical Oversight. 2009.

Holstege, C.P., Holstege, L., Charlton, N.P. “Cocaine-Related Psychiatric Disorders.” eMedicine from WebMD. Updated January 22, 2010. Available at: http://emedicine.medscape.com/article/290195-overview.

Barker, S.J., Charlton, N.P., Holstege, C.P. “Internet accuracy regarding snake envenomation pre-hospital care.” Wilderness Environ Med J 2010;21(1):69-70.

2009

Parker, C., Stern, E., Paglia, E and Brown, C (2009) “Preventable Catastrophe? The Hurricane Katrina Disaster Revisited”. Journal of Contingencies and Crisis Management 17(4)206-220(December).

Crisis Management: Lessons from History for the New Manager-in-Chief Governance by Eric K. Stern

Forrester, J.D., Holstege, C.P. “Injury and Illness Encountered in Shenandoah National Park.” Wilderness Environ Med 2009;20(4):318-326.

Boyle, J.S., Bechtel, L.K., Holstege, C.P. “Management of the critically poisoned patient.” Scan J Trauma Resusc Emerg Med. 2009;17(1):29

Lee, S.D., Charlton, N.P.,Holstege, C.P. “Does the length of QRS interval duration in the poisoned patient correlate with patient outcome?: In BrWJ, Truwit JD (Eds): Critical Decisions in Emergency and Acute Care Electrocardiography. BMJ Pub. 2009. 407-411.

Lawrence, D., McLinskey, N., Huff, J.S., Holstege, C.P. “Toxin Induced Neurologic Emergencies.” In Dobbs MR: Neurology. Elsevier. 2009. 30-46.

Rowden, A.K., Holstege, C.P., Huff, J.S., O’Malley, R.N. “Lead Encephalopathy.” eMedicine from WebMD. Updated October 26, 2009. Available at: http://emedicine.medscape.com/article/1174752-overview

Louters, L.L., Stehouwer, N., Rekman, J., Tidball, A., Cok, A., Holstege, C.P. “Verapamil inhibits the glucose transporter GLUTI.” 2009 North American College of Clinical Toxicology. Clin Toxicol 2009;47(7):733.

Charlton, N.P., Bechtel, L.K., Lawrence, D.T., Haverstick, D.M., Holstege, C.P. “Acetaminophen induced 5-oxoprolinuria.” 2009 North American College of Clinical Toxicology. Clin Toxicol 2009;47(7):751.

Smith, M.B., Charlton, N.P., Thomas, J.J., Boyle, J.S., Holstege, C.P. “Severe Methemoglobinemia: A Case Series.” Clin Toxicol 2009;47(5):481.

2008

Wells, K., Williamson, M., Holstege, C.P., Bear, A.B., Brady, W.J. “The Association of Cardiovascular Toxins and Electrocardiographic Abnormality in Poisoned Patients.” Am J Emerg Med. 2008 Oct;26(8):957-9.

Blizzard, J.C., Michels, J.E., Richardson, W.H., Reeder, C.E., Schulz, R., Holstege, C.P. “Cost-benefit analysis of a regional poison center.” Clin Toxicol 2008 46(5):450-456.

Bechtel, L.K., Haverstick, D.M., Holstege, C.P. “Verapamil Toxicity Dysregulates the Phosphatidylinositol 3-Kinase Pathway.” Acad Emerg Med 2008;15(4):368-374.

Althoff, S.O., Holstege, C.P. “Hyphema.” Ann Emerg Med 2008;52(5):572,598.

Wincester, D.E., Holstege, C.P. “In response to Levine et al. Regarding Hyperglycemia after Calcium Channel Blocker Overdose (letter).” Crit Care Med 2008;36(2):662.

Holstege, C.P., Dobmeier, S.G., Bechtel, L.K. “Critical Care Toxicology.” Emerg Med Clin NA. 2008;26(3):715-739.

Tibballs, J., Holstege, C.P., Wheeler, D.S.: “Envenomations.” In D.S. Wheeler, H.R. Wong, & T.P. Shanley (eds): Pediatric Critical Care Medicine: Basic Science and Clinical Evidence. Springer-Verlag. London. 2008.

Holstege, C.P., Bassin, S.: “Nerve Agents.” In Biller J(ed): The Interface of Neurology of Internal Medicine, 6th Edition. Lippincock Williams & Wilkins, Philadelphia, PA. 2008: 926-932.

Bechtel, L.K., Charlton, N.P., Holstege, C.P. “Glucose uptake sensitivity in adipose and cardiac cells in response to three classes of calcium channel blockers.” Clin Toxicol 2008;46(7):593.

Lawrence, D.T., Bechtel, L.K., Charlton, N.P., Bolye, J.S., Kirk, M.A., Holstege, C.P. “Falsely elevated lactate measurement after ethylene glycol ingestion.” Clin Toxicol 2008;46(7):704.

Bechtel, L.K., Lawrence, D.T., Holstege, C.P. “Cross-reactivity of Veratrum viride steroid alkaloid compounds with a digoxin clinical chemistry assay.” Clin Toxicol 2008;46(7):638.

Holstege, C.P., Charlton, N. “Lacosamide overdose induced status epilepticus treated with hemodialysis.” Clin Toxicol 2008;46(5):364.

Holstege, C.P., Charlton, N. “Focal seizure activity following intentional isoniazid overdose.” Clin Toxicol 2008;46(5):363.

Stanford, C.F., Schaeffer, T.H., Delgado, J., Holstege, C.P., Olsen, D., Bogdan, G.M., Heard, K. “Treatment of life threatening digoxin toxicity with digoxin immune fab.” J Clin Tox 2008; 45(6):647.

Stanford, C.F., Bebarta, V., Holstege, C.P., Bush, S.P., Richardson, W.H., Olsen, D., Dart, R.C. “Is Crotaline fab antivenom efficacious for severe envenomations?” J Clin Tox 2008;45(6):619-20.

Stanford, C.F., Bush, S.P., Clark, R.F., Arnold, T.A., Haynes, J., Holstege, C.P., Bogdan, G.M., Garcia, W., Smith, J.P., Dart, R.C. “A new FAB2 antivenom for widow spider envenomation (latrodectism).” J Clin Tox 2008;45(6):619.

Kell, S., Lawrence, D., Holstege, C.P., Kirk, M.A. “Efficacy of a student-centered approach using human patient simulation in teaching the treatment of venomous snakebites in a medical toxicology rotation.” J Clin Tox 2008;45(6):606.

Rowden, A.K., Holstege, C.P., Kirk, M.A. “Pediatric copperhead envenomations.” J Clin Tox 2008;45(6):644.

2007

Crisis Guide to Psychoactive Drugs and Poisons Crisis Negotiation Unit, Critical Incident Response Group by Greg Saathoff, M.D., Kenneth H. Brasfield, Pharm.D., and Christopher P. Holstege, M.D.

Saathoff, Gregory B., “Critical Intelligence, Communication and Response: Formatting Lessons of the Recent Terrorist Attacks to Future Threats.” Monograph foreword, Critical Incident Analysis Group, University of Virginia, 2007.

Martin-Gill, C., Baer, A.B., Holstege, C.P., Eldridge, D.L., Pines, J.M., Kirk, M.A. “Poison centers as information resources for EMS in a suspected chemical exposure.” J Emerg Med 2007;32(4):397-403.

Lawrence, D., Bechtel, L.K., Walsh, J.P., Holstege, C.P. “The Evaluation and Management of Acute Poisoning Emergencies.” Minerva Med. 2007 Oct;98(5):543-68.

Dovgalyuk, J., Holstege, C.P., Mattu, A., Brady, W.J. “The Electrocardiogram in the Patient with Syncope.” Am J Emerg Med. 2007 Jul;25(6):688-701.

Delk, C., Holstege, C.P., Brady, W.J. “Electrocardiographic abnormalities associated with poisoning.” Am J Emerg Med. 2007 Jul;25(6):672-87.

Brady, W.J., Mitchell, S., Ferguson, J.D., Holstege, C.P.: “An Algorithmic Interpretation of the ECG– The Adult Chest Pain Patient with Electrocardiographic ST Segment Elevation: AMI vs STEMI Mimic?” EMedHome [serial online]. 2007. http://www.emedhome.com/.

Ait-Daoud, N., Holstege, C.P., Dobmeier, S. “The role of valproate induced hyperammonemia in suicidal patients. A case series.” The Journal of the European College of Neuropsychopharmacology 2007; 17 (4):S311. Presented: The 20th European College Neuropsychopharmacology Congress. Vienna, Austria. October 2007.

Bechtel, L., Holstege, C.P. “High dose insulin reverses calcium channel blocker inhibition of glucose uptake in an adipocyte model. Acad Emerg Med 2007;14(5):S51.

Bechtel, L., Holstege, C.P. “Verapamil toxicity induces dysregulation of the insulin- dependent phosphatidylinositol 3-kinase pathway.” Acad Emerg Med 2007;14(5):S51.

Holstege, C.P. “Herbal Medicines–Be Informed.” Vital Signs. Daily Progress. Charlottesville, Virginia. July 1, 2007:E3.

2006

The Family Guide to Preventing and Treating Accidental Poisoning Inside and Outside the Home Stewart, Tabori, & Chang by Christopher P. Holstege, M.D. and Carol Ann Turkington

Barlotta, K.S., Holstege, C.P., Brady, W.J., Mattu, A. “Apparent wide complex tachycardia after ventricular fibrillation cardiac arrest in patients with ST-segment elevation myocardial infarction.” Am J Emerg Med. 2006;24(3):362-7.

Self, W.H., Mattu, A., Martin, M., Holstege, C.P., Preuss, J., Brady, W.J: “Body surface mapping in the ED evaluation of the patient with chest pain: use of the 80-lead electrocardiogram system.” Am J Emerg Med. 2006;24(1):87-112.

Dorf, E., Kuntz, A., Kelsey, J., Holstege, C.P. “Lidocaine-induced altered mental status and seizure following hematoma block.” J Emerg Med 2006;31(3): 251-253.

Holstege, C.P., Powers, R.D. “Anyone, Anything, Anytime – A History of Emergency Medicine (book review).” JAMA 2006;295(7):832-833.

Holstege, C.P., Singletary, E.N. “Skin findings associated with application of a suction device following snake envenomation.” Ann Emerg Med 2006;48(1): 105.

Holstege, C.P., Dobmeier, S.: “Criminal Poisoning – Munchausen’s by Proxy.” Clinics in Laboratory Medicine 2006;26(1):243-254.

Furbee, R.B., Holstege, C.P.: “Hepatotoxicity Associated with Herbal Products.” Clinics in Laboratory Medicine 2006;26(1):227-242.

Eldridge, D.L., Holstege, C.P.: “Utilizing laboratory testing in the poisoned patient.” Clinics in Laboratory Medicine 2006;26(1):13-30.

Holstege, C.P., Eldridge, D.L., Rowden, A.: “Electrocardiographic changes associated with poisoning.” Emerg Med Clin NA 2006 Feb;24(1):159-177.

Holstege, C.P., Isom, G.E., Kirk, M.A.: “Cyanide.” In Goldfrank, et al (eds): Goldfrank’s Toxicologic Emergency, 8 Edition. Appleton & Lange, East nciesthNorwalk, CT. 2006:1712-1724.

Holstege, C.P., Kirk, M.: “Smoke inhalation.” In Goldfrank, et al (eds): Goldfrank’s Toxicologic Emergency, 8 Edition. Appleton & Lange, East Norwalk, CT. 2006:1749-1757.

Singletary, E.M., Holstege, C.P.: “Bites & stings.” In Aghabhabian RV (ed): Essentials of Emergency Medicine. Jones & Barlett Pub. Sudbury MA. 2006:771-780.

Lawrence, D.T., Holstege, C.P., Clark, K.: “Toxicity, Iron.” Pediatrics. EMedicine Journal [serial online]. 2006.

Reilly, T., Holstege, C.P., Aubin, C.D., Mullins, M.E.: “Toxicity, Theophylline.” Pediatrics. eMedicine Journal [serial online]. 2006.

Holstege, C.P., Reilly, T., Hostetler, M.A.: “Toxicity, Plants – Caladium, Dieffenbachia, and Philodendron.” Pediatrics. eMedicine Journal [serial online]. 2006.

Rowden, A.K., Boylan, V.V., Wiley, S.H., Holstege, C.P., Kirk, M.A. “CroFab use for copperhead envenomation in the young.” Clin Toxicol. 2006;44(5):696-697.

Roden, A.K., Martindale, J.R., Wiley, S.H., Boylan, V.V., Holstege, C.P., Kirk, M.A. “The relationship of snake bites and weather patterns.” Clin Toxicol. 2006;44(5):669.

Rowden, A.K., Holstege, C.P., Martindale, J.R., Eldridge, D.L., Kirk, M.A. “Time-delay to confirmatory blood lead levels.” Clin Toxicol. 2006;44(5):720.

Rowden, A.K., Holstege, C.P., Martindale, J.R., Eldridge, D.L., Kirk, M.A. “Time-delay of confirmatory methanol and ethylene glycol levels.” Clin Toxicol. 2006;44(5):738-739.

Reilly, T., Holstege, C.P., Kirk, M.A. “Material Safety Data Sheet (MSDS) inconsistencies pertaining to N, N diethyl-m-toluamide (DEET).” Clin Toxicol 2006;55(5):771.

Michels, J.E., Blizzard, J.C., Holstege, C.P., Richardson, W. “Cost-benefit analysis of poison center phone services.” Clin Toxicol. 2006;44(5):669.

Eldridge, D.L., Rowden, A.K., Holstege, C.P., Kirk, M.A. “Intentional ingestion of Roxarsone (3-Nitro-4-Hydroxyphenylarsonic acid) with subsequent elevated liver enzymes.” Clin Toxicol. 2006;44(5):760.

Kirk, M.A., Holstege, C.P. “Chemical toxic syndrome recognition: a strategy to simplify training first responders and hospital personnel about hazardous chemical emergencies.” Clin Toxicol 2006;44(4):439.

Holstege, C.P., Eldridge, D.L., Kirk, M.A. “Spontaneous decrease of elevated blood lead levels despite retained intracranial lead shotgun pellets.” Clin Toxicol 2006;44(4):439.

Kirk, M.A., Holstege, C.P. “Delayed presentation of prolonged QTc leading to the diagnosis of occult citalopram poisoning.” Clin Toxicol 2006;44(4):494.

2005

Moye, S., Carney, M.F., Holstege, C.P., Mattu, A., Brady, W.J.: “The electrocardiogram in right ventricular myocardial infarction.” Am J Emerg Med. 2005 Oct;23(6):793-9.

Hollowell, H., Mattu, A., Perron, A.D., Holstege, C.P., Brady, W.J.: “Wide complex tachycardia: Beyond the traditional differential diagnosis of ventricular versus supraventriculartachycardia with aberrant conduction.” Am J Emerg Med. 2005 Nov;23(7):876-889.

Holstege, C.P., Baer, A.B., Brady, W.J.: “The electrocardiographic toxidrome: The ECG presentation of hydrofluoric acid ingestion.” Am J Emerg Med 2005;23:171-176.

Holstege, C.P. “Clinical Toxicology: Principles and Mechanisms (Book Review).” Clin Chem. 2005;51(4):795-796.

Holstege, C.P. “Petechiae and purpura associated with meningococcemia.” Ann Emerg Med 2005;45(5):560.

Holstege, C.P. “Skin findings associated with a lightning strike.” Ann Emerg Med. 2005;45(4):354.

Holstege, C.P., Eldridge, D.L., Baer, A.B.: “Air emboli and respiratory distress following central venous catheter removal.” Ann Emerg Med 2005;45(3):335,342.

Holstege, C.P., Dobmeier, S.G.: “Nerve agent toxicity and treatment.” Curr Treat Options Neurol. 2005;7:91-98.

Holstege, C.P., Mitchell, K., Barlotta, K., Furbee, B.: “Toxicity and Drug Interactions Associated with Herbal Products: Ephedra and St John’s Wort.” Med Clin NA 2005;89(6):1225-1258.

Singletary, E., Rochman, A.S., Bodmer, J.C.A., Holstege, C.P.: “Envenomations.” Med Clin NA 2005;89(6):1195-1224.

Eldridge, D.L., Dobson, T., Brady, W.; Holstege, C.P.: “Utilizing diagnostic investigations in the poisoned patient.” Med Clin NA 2005;89(6):1079-1106.

Holstege, C.P., Dobmeier, S.: “Cardiovascular complications associated with poisoning.” Emerg Med Clin NA 2005;23(4):1195-1218.

Holstege, C.P., Eldridge, D.E., Rowden, A.K. “Highly toxic ingestions: When “just a little” is far too much.” Pediatric Emergency Medicine Practice. 2005;2(7).

Holstege, C.P. “Acetylsalicyclic acid.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;1:36-8.

Baer, A.B., Holstege, C.P. “Barbituates, Long-Acting.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;1:209-10.

Baer, A.B., Holstege, C.P. “Barbituates, Short-Acting.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;1:211-2.

Holstege, C.P. “Benzodiazepines.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;1:260-2.

Holstege, C.P. “Buckthorn.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;1:349-50.

Holstege CP. “Caffeine.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;1:377-9.

Eldridge, D.L., Holstege, C.P. “Ciguatoxin.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;1:610-1.

Baer, A.B., Holstege, C.P. “Diphenoxylate.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;2:73-4.

Holstege, C.P. “Ergot.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;2:235-6.

Holstege, C.P. “Ethylene glycol.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;2:287-8.

Holstege, C.P. “Ethylene glycol monoethyl ether.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;2:289-90.

Eldridge, D.L., Holstege, C.P. “Heparin.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;2:500-2.

Holstege, C.P. “Hydrazine.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier, Ltd, Oxford, UK. 2005;2:536-7.

Holstege, C.P. “Hydrochloric acid.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK 2005;2:538-40.

Holstege, C.P. “Hydocodone.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier, Ltd, Oxford, UK. 2005:2:540-1.

Eldridge, D.L., Holstege, C.P. “Hydrogen peroxide.” In Wexler P (ed):Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;2:543-5.

Holstege, C.P. “Hydromorphone.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier LTD, Oxford, UK. 2005;2:552-3.

Holstege, C.P. “Ibuprofen.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK 2005;2:566-7.

Holstege, C.P. “Levothyroxine.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:711-2.

Holstege, C.P. “Lidocaine.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 205;2:714-5.

Holstege, C.P. “LSD.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;2:750-1.

Holstege, C.P. “Marijuana.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:14-5.

Holstege, C.P. “Medical surveillance.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:26-7.

Eldridge, D.L., Holstege, C.P. “Meprobamate.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:29-31.

Holstege, C.P. “Mescaline.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:40-1.

Holstege, C.P. “Methaqualone.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:56-7.

Baer, A.B., Holstege, C.P. “Methylenedioxymethamphetamine.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:96-7.

Eldridge, D.L., Holstege, C.P. “Metronidazole.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:103-4.

Holstege, C.P. “Mistletoe.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:116-7.

Holstege, C.P. “Mithramycin.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:117-118.

Holstege, C.P. “Nitroethane.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:240-1.

Holstege, C.P. “Nutmeg.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:276-7.

Holstege, C.P. “Opium.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK.2005;3:299-300.

Holstege, C.P. “Pentazocine.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005; 3:346-7.

Holstege, C.P. “Phenazopyridine.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:394-5.

Holstege, C.P. “Phencyclidine.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:26-7.395-7.

Holstege, C.P. “Poisoning emergencies in humans.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:545-62.

Holstege, C.P. “Procainamide.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:524-5.

Holstege, C.P. “Propoxypene.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:543-4.

Holstege, C.P. “Prunus species.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:555-6.

Baer, A.B., Holstege, C.P. “Ranitidine.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:620-1.

Baer, A.B., Holstege, C.P. “Red squill.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:626-7.

Baer, A.B., Holstege, C.P. “Rhododendron genus.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005; 3:699-700.

Holstege, C.P. “Rifampin.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:705-6.

Baer, A.B., Holstege, C.P. “Salicylates.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;3:761-3.

Holstege, C.P. “Solanum genus.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;4:66.

Holstege, C.P. “American Academy of Clinical Toxicology.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;4:485-6.

Holstege, C.P. “American Association of Poison Control Centers.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;4:487.

Holstege, C.P. “American College of Medical Toxicology.” In Wexler P (ed): Encyclopedia of Toxicology. 2nd Edition. Elsevier Ltd, Oxford, UK. 2005;4:489.

Holstege, C.P. “Selective serotonin reuptake Inhibitors and serotonin syndrome.” In Kazzi ZN, Roberge RJ (eds): AAEM Toxicology Handbook. P.147-149. 2005

Holstege, C.P.: “Valproic acid.” In Kazzi ZN, Roberge RJ (eds): AAEM Toxicology Handbook. p.165-167. 2005.

Holstege, C.P.: “Gastrointestinal decontamination.” In Kazzi ZN, Roberge RJ (eds): AAEM Toxicology Handbook. p. 55-60. 2005.

Holstege, C.P.: “Antipsychotics.” In Kazzi ZN, Roberge RJ (eds): AAEM Toxicology Handbook. p.21-23. 2005.

Holstege, C.P.: “Atypical antidepressants.” In Kazzi ZN, Roberge RJ (eds): AAEM Toxicology Handbook. p. 25-27. 2005.

Holstege, C.P., Brady, W., Baer, A.B., Eldridge, D.L. “The association of cardiovascular toxins and electrocardiographic abnormality in poisoned patients.” J Toxicol Clin Toxicol 2005;43(5):504.

Baer, A.B., Holstege, C.P., Eldridge, D.L. “Serum bicarbonate as a predictor of toxic salicylate levels.” J Toxicol Clin Toxicol 2005;43(5):536.

Holstege, C.P. “Effects of dioxins on human health.” J Toxicol Clin Toxicol 2005;43(5):407-408.

Tenharmsel, A., Holstege, C.P., Louters, L. “High dose insulin reverses verapamil inhibition of glucose uptake in mouse striated muscle.” Ann Emerg Med 2005;46(3):S77.

Rowden, A.K., Eldridge, D.L., Brady, W.J., Holstege, C.P. “The association cardiovascular toxins and electrocardiographic abnormality in poisoned patients.” Ann Emerg Med. 2005;46(3):S35.

Eldridge, D.L., Stoeckle, M.M., Holstege, C.P., Rowden, A.K., Kirk, M.A. “Elevated troponin level and ST wave depression secondary to disulfarim-like reaction resulting from suspected deficit in ethanol metabolism.” J Toxicol Clin Toxicol 2005;43(6):640-1.

Rowden, A.K., Eldridge, D.L., Holstege, C.P. “Delayed partial thickness skin burns following exposure to carboquat (didecyl dimenthyl ammonium carbonate and didecyl dimethyl ammonium bicarbonate).” J Toxicol Clin Toxicol 2005;43(6):751.

Eldridge, D.L., Holstege, C.P. “Massive ibuprofen overdose associated with electrocardiographic changes.” Submitted to J. Toxicol Clin Toxicol 2005;43(6):740-1.

Kell, S.O., Holstege, C.P., Asarkaya, Y. “Poison Education Effects in the Elderly.” J Toxicol Clin Toxicol 2005;43(6):704.

Rowden, A.K., Buck, M.L., Eldridge, D.L., Holstege, C.P. “The radiopacity of ingested transdermal medicinal patches in a simulated human model.” J Toxicol Clin Toxicol 2005;43(6):695.

Rowden, A.K., Eldridge, D.L., Kirk, M.A., Holstege, C.P. “Pulmonary toxicity associated with rapamycin in a pediatric renal transplant patient.” J Toxicol Clin Toxicol 2005;43(6):655-6.

Kell, S.O., Kirk, M.A., Rowden, A.K., Holstege, C.P., Asarkaya, Y. “Effects on learning using human patient simulation in teaching pharmacology principles.” J Toxicol Clin Toxicol 2005;43(6):700.

Eldridge, D.L., Richardson, W., Michels, J.E., Holstege, C.P., Kirk, M.A. “The role of poison centers in a mass chorine exposure.” J Toxicol Clin Toxicol 2005;43(6):766-7.

Rowden, A.K., Calise, A.G., Holstege, C.P. “Influence of marketing on tramadol prescribing practices in an urban teaching hospital.” J Toxicol Clin Toxicol 2005;43(6):766-7.

Holstege, C.P., Fringer, R.C., Sargeant, E. “Safety, efficacy and feasibility of activated charcoal in first aid.” Resuscitation 2005;67:333.

Holstege, C.P. “Safety, efficacy and feasibility of wound suction for pit viper envenomation in first aid.” Resuscitation 2005;67:333.

Judge, J.A., Holstege, C.P. “Safety, efficacy and feasibility of water irrigation in the first aid management of a toxic exposure to the skin and/or eye.” Resuscitation 2005;67:333.

Holstege, C.P. “Lead poisoning remains a risk to Virginia’s children.” Vital Signs. Daily Progress. Charlottesville, Virginia. May 2005:C3.

Mass Evacuation and Our Nation’s Highways — Carolina Planningby Greg Saathoff, M.D. and John B. Noftsinger, Jr., Ed.D.

2004

Holstege, C.P., Ferguson, J.D., Wolf, C.E., Baer, A.B., Poklis, A.: “Analysis of moonshine for contaminants.” J Toxicol Clin Toxicol. 2004;42(5):19-23.

Holstege, C.P., Baer, A.B.: “Critical care neurology – Insecticides.” Curr Treat Options Neurol. 2004;6(1):17-23.

Baer, A.B., Kirk, M.A., Holstege, C.P. “Organophosphates, carbamates, pesticides, and herbicides.” In Erickson, T.B., Ahrens, W.R., Aks, S.E., Baum, C.R., Ling, L.J. (eds): Pediatric Toxicology: Diagnosis and Management of the Poisoned Child. McGraw-Hill Publishing Co. New York, NY. pp. 352-358. 2004.

Holstege, C.P. “Digitalis.” In Chan, T.C., Brady, W.J., Harrigan, R.A., Ornato, J.P., Rosen, P. (eds): ECG in Emergency Medicine and Acute Care. Elsevier-Mosby. Philadelphia, PA. pp. 255-260, 2004.

Holstege, C.P., Baer, A.B.: “Other sodium channel blockers.” In Chan, T.C., Brady, W.J., Harringan, R.A., Ornato, J.P., Rosen, P. (eds): ECG in Emergency Medicine and Acute Care. Elsevier-Mosby. Philadelphia PA. pp. 274-278, 2004.

Rose, S.R., Holstege, C.P.: “Folic acid.” In Brent, J. (ed): Critical Care Toxicology: Diagnosis and Management of the Critically Poisoned Patient. Mosby. Philadelphia, PA. 2004.

Maready, E., Holstege, C.P., Baer, A.B. “Electrocardiographic abnormality in carbon monoxide-poisoned patients.” Ann Emerg Med. 2004;44(4):S92.

Baer, A.B., Kirk, M.A., Eldridge, D.L., Holstege, C.P.: “Profound thrombocytopenia induced by crotalus horridus envenomation unresponsive to CroFab.” J Toxicol Clin Toxicol. 2004;42(5):810.

Baer, A.B., Kirk, M.A., Holstege, C.P.: “Obtaining medical information during a nuclear, biological, or chemical (NBC) incident: a survey study.” J Toxicol Clin Toxicol. 2004:42(5):820-821.

Kirk, M.A., Kell, S., Dobmeier, S., Baer, A.B., Holstege, C.P., Huff, J.S., Jackson, J.M.: “Using new technologies for medical toxicology education.” J Toxicol Clin Toxicol. 2004;42(5):780.

Holstege, C.P., Baer, A.B., Eldridge, D.L., Kirk, M.A., Brady, W.J. “Case series of elevated troponin I following carbon monoxide poisoning.” J Toxicol Clin Toxicol. 2004:42(5):742-743.

Brady, W.J., Dobson, T., Ghaemmaghami, C.A., Burt, D.R., Holstege, C.P.: “ST segment depression in ACS patients.” Acad Emerg Med. 2004.

Holstege, C.P. “Poison proofing the home.” Albemarle Kids Magazine. Spring 2004.

Holstege, C.P. “Return of “Green Fairy” should be red flag.” Vital Signs. Daily Progress. Charlottesville, Virginia. January 25, 2004:C3.

Holstege, C.P., Baer, A.B.: “Incapacitating agents, opioids & benzodiazepines.” Emergency Medicine. eMedicine Journal [serial online]. 2004. http://www.emedicine.com/emerg/topic944.htm

2003

Saathoff,G.B. “Critical Incident Analysis Group and Community Shielding Concept.” The CIP Report, 2:3, 2003.

Holstege, C.P., Hunter, Y., Baer, A.B., Savory, J., Bruns, D.E., Boyd, J.C. “Massive caffeine overdose requiring vasopressin infusion and hemodialysis. J Toxicol Clin Toxicol. 2003;41(7):1003-1007.

Holstege, C.P.: “Proper treatment of anaphylaxis (letter).” Ann Emerg Med. 2003;41(3):425-426.

Holstege, C.P.; Baer, A.B.; Kirk, M.A.; Brady, W.J. “Cardiotoxins.” Emerg Med Reports. 2003;24(14):187-198.

Holstege, C.P., Baer, A.B.: “Decontamination of the poisoned patient.” In Roberts, J.R. & Hedges, J.R. (eds): Clinical Procedures in Emergency Medicine, 4th Edition. Saunders, Philadelphia, PA. p. 824-840. 2003.

Holstege, C.P.: “Organophosphate poisoning.” In Keim, S.M. (ed): Emergency Medicine on Call. McGraw-Hill, New York, NY. p. 353-355, 2003.

Holstege, C.P.: “Elder abuse”: In by Keim, S.M. (Ed): Emergency Medicine on Call. McGraw-Hill, New York, NY. P. 304-307, 2003.

Kurz, M.C., Brady, W.J., Beagle, C., Perron, A.D., Ullman, E.A., Holstege, C.P., Riviello, R.J., Ripley, A., Ghaemmaghami, C.A.: “Can initial ECG predict peak troponin I? A biostatistical approach.” Ann Emerg Med. 2003;42(4):S30.

Holstege, C.P., Horn, J.R., Horn, S.M., Kell, S.O., Baer, A.B., Kirk, M.A.: “Survey of first responders and health department official’s knowledge of poison center services.” J Toxicol Clin Toxicol. 2003;41(5):697.*

Holstege, C.P., Baer, A.B., Kirk, M.A.: “Prolonged hallucinations following ingestion of alpha-methyl-tryptamine.” J Toxicol Clin Toxicol. 2003;41(5):746.*

Kirk, M.A., Dobmeier, S.G., Holstege, C.P., Kell, S.O.: “Multiple communications for poison centers during mass chemical exposure.” J Toxicol Clin Toxicol. 2003;41(5):697.

Kirk, M.A., Baer, A.B., Holstege, C.P., Martin, M.L.: “Nasal button battery impaction as cause of periorbital cellulitis and corrosive tissue injury.” J Toxicol Clin Toxicol. 2003;41(5):679.

Kell, S., Dagenais, J., Farrar, R., Holstege, C.P. “Time saving archive for educators.” J Toxicol Clin Toxicol. 2003;31(5):709-710.

Ferguson, J.D., Holstege, C.P., Wolf, C.E., Baer, A.B., Poklis, A. “Analysis of moonshine for contaminants.” Acad Emerg Med 2003 May; 10(5):511.*

Kell, S.O., Holstege, C.P. “Poison Safety for the Holidays: Quick Guide to Common Holiday Hazards and First Aid.” Albemarle Family Magazine. 2003;Winter:18-19.

Holstege, C.P. “Keep household poisons under wraps.” Daily Progress. Charlottesville, Virginia. March 23, 2003:C7.

Holstege, C.P., Holstege, L.J., Baer, A.: “Cocaine-related psychiatric disorders.” Medicine, OB/Gyn, Psychiatry, and Surgery. eMedicine Journal [serial online]. 2003. http://www.emedicine.com/med/topic3116.htm

2002

Saathoff, Gregory B., “Public Responsibility and Mass Destruction: Facing the Threat of Bioterrorism.” monograph foreword, Critical Incident Analysis Group, University of Virginia, 2002.

Saathoff, Gregory B, “What is to be Done? Emerging Perspectives on Public Responses to Bioterrorism.” monograph foreword, Critical Incident Analysis Group, University of Virginia, Bailey Press, 2002.

Prior, S, Rowan, F, Saathoff, Gregory B. “What is to be Done? Emerging Responses to Bioterrorism.” Introduction, Critical Incident Analysis Group, University of Virginia, Bailey Press, 2002.

Saathoff, G, Psychological Challenges of Bioterror; Containing Contagion,“What is to be Done? “Emerging Perspectives on Public Responses to Bioterrorism.” monograph foreword, Critical Incident Analysis Group, University of Virginia, Bailey Press, 2002.

Saathoff, G, Everly, G, Psychological Challenges of Bioterror: Containing Contagion. International Journal of Emergency Mental Health, 4:4,2002,245-252.

Prior, S, Rowan,F, Saathoff, G, Foundations of Shielding. International Journal of Emergency Mental Health, 4:4, 2002, 235-238.

Kanich, W., Brady, W.J., Huff, J.S., Perron, A.D., Holstege, C.P., Lindbeck, G., Carter, C.T.: “Altered mental status: Evaluation and etiology in the emergency department.” Am J Emerg Med. 2002 Nov;20(7):613-617.

Brady, W.J., Perron, A.D., Ullman, E.A., Syverud, S.A., Holstege, C.P., Riviello, R., Ghammaghami, C. “Electrocardiographic ST segment elevation: a comparison of AMI and non-AMI ECG syndromes.” Am J Emerg Med. 2002;20(7):609-612.

Brady, W.J., Perron, A.D., Syverud, S.A., Beagle, C., Riviello, R.J., Ghaemmaghami, C.A., Ullman, E.A., Erling, B., Ripley, A., Holstege, C.P. “Reciprocal ST segment depression: Impact on the electrocardiographic diagnosis of ST segment elevation acute myocardial infarction.” Am J Emerg Med. 2002;20(1):35-38.

Holstege, C.P., Wu, J., Baer, A.: “Immediate hypersensitivity reaction associated with the rapid infusion of Crotalidae Immune Fab (CroFab).” Ann Emerg Med. 2002;39(6):677-679.

Holstege, C.P., Baylor, M., Rusyniak, D.: “Absinthe: The return of the green fairy.” Semin in Neurol. 2002;22(1):89-93.

Holstege, C.P., Kirk, M.: “Smoke inhalation.” In Goldfrank, et al (eds): Goldfrank’s Toxicologic Emergencies, 7th Edition. Appleton & Lange, East Norwalk, CT p. 1469-1477, 2002.

Holstege, C.P., Kell, S., Baer, A.B., Fatovitch, T. “Prevalence of Oxycontin Abuse in High School Students.” J Toxicol Clin Toxicol 2002;40(5):656.

Baylor, M., Holstege, C.P., Baer, A.B. “Case series of prolonged choreoathetosis, fever, and hallucinations following pemoline ingestion.” J Toxicol Clin Toxicol 2002;40(5):682.

Baer, A.B., Holstege, C.P. “Milrinone overdose induced hypotension reversed by vasopressin and norepinephrine infusions.” J Toxiol Clin Toxicol 2002;40(5):690.

Holstege, C.P., Kirk, M.A. “Snakebites – myths & reality.” Daily Progress. Charlottesville, Virginia. July 28, 2002:E3.

Holstege, C.P. “Do your homework on herbal medicine. Daily Progress. Charlottesville, Virginia. February 17, 2002:E3

Circling the Wagons: Community-Based Responses to Bioterrorism — by Ambassador W. Nathaniel Howell, Ph.D.

September 11th through Conspiracists’ Eyes — by Michael Barkun, Maxwell School – Syracuse University

Government Organizational Issures Related to Counter-Terrorism — Statement by George J. Terwilliger III

2001

Brady, W.J., Syverud, S.A., Beagle, C., Perron, A.D., Ullman, E.A., Holstege, C.P., Riviello, R.J., Ripley, A., Ghaemmaghami CA. “Electrocardiographic ST-segment elevation: The diagnosis of acute myocardial infarction by morphological analysis of the ST segment.” Acad Emerg Med. 2001;8(10):961-967.

Sweet, J.M., Holstege, C.P.: “Fatal bone marrow failure from medication error: diagnosis by history, not biopsy.” Arch Intern Med. 2001;161(15):1911-1912.

Holstege, C.P., Baylor, M.: “Incapacitating agents, 3-quinuclidinyl benzilate.” Emergency Medicine. eMedicine Journal [serial online]. 2001. http://www.emedicine.com/emerg/topic915.htm

Holstege, C.P., Baylor, M.: “Vomiting agents: Dm, Da, Dc.” Emergency Medicine. eMedicine Journal [serial online]. 2001. http://www.emedicine.com/emerg/topic915.htm

Holstege, C.P., Baer, A.: “Pleurisy.” In Alder, et al (eds): AAEM Emergency Medical and Family Health Guide. eMedicine.com, Inc. Omaha, NE, 2001.

Holstege, C.P.: “Smoke inhalation.” In Alder, et al (eds): AAEM Emergency Medical and Family Health Guide. eMedicine.com, Inc. Omaha, NE, 2001.Holstege, C.P., Baer, A.B., Baylor, M., Thompson, J. “Retained gastric lead foreign body resulting in markedly elevated blood levels in two children.” J Toxicol Clin Toxicol 2001;39(5):550*

Holstege, C.P., Mullins, M., Baer, A.B. “Hypotension induced by massive caffeine overdose responsive only to vasopressin infusion.” J Toxicol Clin Toxicol 2001;39(5):513.*

Kell, S., Holstege, C.P., Thompson, J.: “Current ipecac recommendations, what does it mean for future national materials?” J Toxicol Clin Toxicol 2001;39(5):513.*

Brady, W., Syverud, S., Beagle, C., Perron, A., Holstege, C., Riviello, R., Ripley, A., Ghaemmaghami, C. “The effect of electrocardiographic ST-segment depression on the electrocardiographic diagnosis of ST-segment elevation acute myocardial infarction.” Ann Emer Med 2001;38(4):S92.

Holstege, C.P., Brown, P., Carr, B. “Prevalence of complimentary and alternative medicine use in the pediatric emergency department.” Ann Emerg Med 2001;38(4):S49-50.*

Holstege, C.P., Baylor, M., Rusyniac, D., Brady, W. “Lidocaine: Do emergency health care providers know the correct dose?” Ann Emerg Med 2001;38(4):S60.*

Brady, W.J., Syverud, S.A., Beagle, C., Ullman, E.A., Perron, A.D., Riviello, R., Holstege, C.P., Ripley, A., Ghaemmaghami, C. “ST-segment elevation: analysis of the waveform morphology in the ED diagnosis of AMI.” Academic Emergency Medicine 2001;8(5):554.

Holstege, C.P.: “Herbal Toxicology.” Audi-Digest Emergency Medicine. 2001;18(3).

The CDC’s Public Health Response to the Threat of Bioterrorism — Statements by James M. Hughes, M.D.Director, National Center for Infectious Diseases

Bioterrorism: Legal Initiatives for Prevention/Deterrence — by Barry Kellman, DePaul UniversitySuzanne Spaulding, National Commission on Terrorism

Public Responsibility and Mass Destruction: The Bioterrorism Threat — CIAG 2001 Conference Proceedings

2000

Muniz, A., Holstege, C.P.: “Acute myocardial infarction associated with sildenafil (Viagra) ingestion.” Amer J Emerg Med. 2000;18(3):353-355.st1:*

Holstege, C.P., Holstege, H.: “Elder abuse”, In Fink (ed.): Encyclopedia of Stress, 1st Edition. Academic Press, San Diego, CA. p. 19-23, 2000.

Kell, S., Oneida, B., Thompson, J., Holstege, C.P. “Intranet system – a valuable tool.” J Toxicol Clin Toxicol 2000;38:565.

Holstege, C.P. “Carbon monoxide is a silent indoor killer.” Daily Progress. Charlottesville, Virginia. December 31, 2000: E3.

1999

Rose, R., Carper, B., Waring, E., Holstege, C.P., Cisek, J. “Utilization of caller ID technology among certified poison centers.” J Toxicol Clin Toxicol 1999;37(5):590.

Holstege, C.P., Snyder, L., Cisek, J., Rose, R. “Profound methemoglobinemia induced by dermal and inhalational exposure to aniline dye.” J Toxicol Clin Toxicol 1999;37(5):621.*

Waring, E., Holstege, C.P., Rose, S.R., Cisek, J. “Transient miosis and contact dermatitis from Bombina bombina exposure.” J Toxicol Clin Toxicol 1999;37(5):615.

Cisek, J., Holstege, C.P., Rose, R. “Seizure associated with butanediol ingestion.” J Toxicol Clin Toxicol 1999;37(5):650.

Valez, J., Holstege, C.P.: “Toxicology Emergencies.” EMSAT Broadcast, Office of Emergency Medical Services, Virginia Department of Health. December 1999.

1998

Kirk, M., Holstege, C.P.: “Smoke inhalation”, In Goldfrank, et al (eds): Goldfrank’s Toxicologic Emergencies, 6th Edition. Appleton & Lange, East Norwalk, CT. p. 1539-1550, 1998.

Seifert, S., Holstege, C.P., Furbee, R.B., Kirk, M.A. “Organ procurement after brodifacoum poisoning.” J Toxicol 1998;36(5):509*

Holstege, C.P., Kirk, M.A., Furbee, R.B., Wermuth, M.E. “Wide complex dysrhythmia in calcium channel blocker overdose responsive to sodium bicarbonate therapy.” J Toxicol Clin Toxicol 1998;36(5):509.*

1997

Jones, J.S., Holstege, C.P., Holstege, H.: “Elder abuse and neglect: Understanding the causes and potential risk factors.” Amer J Emerg Med.1997;15(6):579-583.
Holstege, C.P., Miller, M.B., Wermuth, M., Furbee, B., Curry, S.C.: “Crotalid snake envenomation.” Crit Care Clin. 1997;13(4):889-921.

1995

Hubbard, J.R.; Saathoff, G.B.; Bernardo, J.J.; Barnett, B.L.: “Recognizing Borderline Personality Disorder in the Family Practice Setting. American Family Physician, 52:3, 908-925, 1995.

Jones, J.S., Holstege, C.P., Riekse, R., White, L., Bergquist, T.: “Metered-dose inhalers: Do emergency health care providers know what to teach?” Ann Emerg Med. 1995;26(3):308-311.

Jones, J.S., Riekse, R., Holstege, C.P., White, L., Bergquist, T. “Metered-dose inhalers: do emergency health care providers know what to teach?” Academic Emergency Medicine 1995.*

1992

Saathoff, G.B.; Cortina, J.A.; Jacobson, R.; Aldrich, C.K.: “Mortality Among Elderly Patients Discharged from a State Hospital. ” Hospital and Community Psychiatry, 3:43, pp. 280-281, March 1992.

1991

Saathoff, Gregory B.: “Current Psychiatric Research Instruments.” book review, Contemporary Psychology, pp. 335-336, April 1991.

1990

Saathoff, G.B.: “Policeman’s Unique Position is Stressor in Psychiatric Evaluation.” The Psychiatric Times, pp. 50-51, September, 1990.

1989

Vieweg, W.V.R.; Godleski, L.S.; Pulliam, W.R.; Schofield, W.P.; Saathoff, G.B.; Hundley, P.L.; and Yank, G.R.: “Development of Water Dysregulation During Arieti’s Third Stage of Schizophrenia?” Biol Psychiatry, 26: 775-780, 1989.

1988

Holstege, C.P., Pickaart, M.J., Louters, L.L.: “Separation of RNA and DNA by histone affinity high-performance liquid chromatography.” J Chromatog. 1988;455:401-405.

1987

Canterbury, R.J.; Haskins, B.; Kahn, N.; Saathoff, G.B.; Yazel, J.: “Post-partum Psychosis Induced by Bromocriptine.” Southern Medical Journal, November, 1987. p. 1463.